OCS SILICA INC_product portfolio_2013.
List of Pharmaceutical Companies who will used the Genuine Silica:
| Rank |
Company |
Country |
Total Revenues(USD billions) |
Total Revenues(reported currency in millions) |
Change 09/08 (%) |
Net income/ (loss)(reported currency in millions) |
Change 09/08 (%) |
R&D Expenses(reported currency in millions) |
Change 09/08 (%) |
Fortune 500 Ranking[1] |
| 1 | Johnson & Johnson[2] | United States |
61.90[3] |
$61,897 |
-2.9 |
$12,266 |
-5.3 |
6,986 |
-7.8 |
103 |
| 2 | Pfizer[4] | United States |
50.01[3] |
$50,009 |
3.5 |
8,635 |
6.6 |
7,845 |
-1.3 |
152 |
| 3 | Roche[5] | Switzerland |
47.35[3] |
49,051 CHF |
7.5 |
8,510 CHF |
-21.5 |
9,874 CHF |
11.6 |
171 |
| 4 | GlaxoSmithKline[6] | United Kingdom |
45.83[3] |
£28,368 |
16.5 |
£5,669 |
20.3 |
£4,106 |
11.5 |
168 |
| 5 | Novartis[7] | Switzerland |
44.27[3] |
$44,267 |
6.8 |
$8,454 |
3.6 |
$7,469 |
3.5 |
183 |
| 6 | Sanofi[8] | France |
41.99[3] |
€29,306 |
6.3 |
€8,471 |
17.9 |
€4,583 |
0.2 |
181 |
| 7 | AstraZeneca[9] | UK/Sweden |
32.81[10] |
$32,804 |
3.8 |
$7,544 |
23.1 |
$4,409 |
-14.9 |
268 |
| 8 | Abbott Laboratories[11] | United States |
30.76[10] |
$30,765 |
4.2 |
5,746 |
21.4 |
2,744 |
2.1 |
294 |
| 9 | Merck & Co.[12] | United States |
27.43[10] |
$27,428 |
15.0 |
$13,024 |
64.2 |
$5,800 |
20.8 |
378 |
| 10 | Bayer HealthCare[13] | Germany |
22.30 |
€15,988 |
3.8 |
€1,696 |
38.8 |
€1,845 |
5.9 |
154 |
| 11 | Eli Lilly[14] | United States |
21.84[15] |
$21,836 |
7.2 |
$4,328 |
N/A |
N/A |
N/A |
455 |
| 12 | Bristol-Myers Squibb[16] | United States |
18.81[17] |
$18,808 |
6.2 |
$4,420 |
19.9 |
3,647 |
3.8 |
435 |
|
Rank[30] |
Company |
Country |
Total Revenues(USD millions) |
Healthcare R&D 2008(USD millions) |
Net income/ (loss) 2008(USD millions) |
Employees 2008 |
|
1 |
Pfizer[33] (with Wyeth[34]) | United States |
70,696 |
11,318 |
14,111 |
137,127 |
|
2 |
Johnson & Johnson | United States |
63,747 |
NA |
10,576 |
119,200 |
|
3 |
Hoffmann–La Roche | Switzerland |
43,970 |
NA |
8,135 |
78,604 |
|
4 |
Novartis | Switzerland |
41,460 |
NA |
11,946 |
98,200 |
|
5 |
GlaxoSmithKline | United Kingdom |
40,424 |
6,373 |
10,432 |
103,483 |
|
6 |
Sanofi-Aventis | France |
40,328 |
NA |
7,204 |
99,495 |
|
7 |
AstraZeneca | United Kingdom/Sweden |
31,601 |
NA |
5,959 |
67,400 |
|
8 |
Abbott Laboratories[35] | United States |
29,527 |
2,688 |
4,880 |
68,697 |
|
9 |
Merck & Co. | United States |
23,850 |
4,678 |
7,808 |
74,372 |
|
10 |
Bristol-Myers Squibb | United States |
19,977 |
NA |
2,165 |
42,000 |
|
11 |
Eli Lilly and Company | United States |
18,634 |
NA |
2,953 |
40,600 |
|
12 |
Boehringer Ingelheim | Germany |
16,959 |
1,977 |
2,163 |
43,000 |
|
13 |
Takeda Pharmaceutical Co. | Japan |
15,697 |
1,620 |
2,870 |
15,000 |
|
14 |
Bayer [36] | Germany |
15,407 |
3,770 |
6,448 |
108,600 |
|
15 |
Amgen | United States |
14,771 |
3,366 |
3,166 |
48,000 |
|
16 |
Genentech | United States |
13,400 |
15773 |
3,640 |
33,500 |
|
17 |
Baxter International | United States |
12,300 |
614 |
1,397 |
38,428 |
|
18 |
Teva Pharmaceutical Industries | Israel |
11,080 |
495 |
546 |
26,670 |
|
19 |
Astellas Pharma | Japan |
10,701 |
1,435 |
1,122 |
23,613 |
|
20 |
Daiichi Sankyo | Japan |
9,682 |
1,459 |
671 |
20,100 |
|
21 |
Novo Nordisk | Denmark |
9,081 |
1,063 |
1,922 |
26,575 |
|
22 |
Procter & Gamble | United States |
8,964 |
NA |
10,340 |
29,258 |
|
23 |
Eisai | Japan |
5,583 |
926 |
604 |
14,993 |
|
24 |
Merck KGaA | Germany |
5,175 |
772 |
1,258 |
13,900 |
|
25 |
Alcon | United States |
4,897 |
512 |
1,348 |
13,500 |
|
26 |
SINOPHARM | China |
4,700 |
498 |
1249 |
9700 |
|
27 |
Akzo Nobel | Netherlands |
4,694 |
741 |
1,449 |
13,000 |
|
28 |
UCB | Belgium |
4,426 |
1,024 |
492 |
12,741 |
|
29 |
Nycomed | Switzerland |
4,264 |
NA |
-105 |
10,533 |
|
30 |
Forest Laboratories | United States |
3,442 |
941 |
454 |
9,649 |
|
31 |
Solvay | Belgium |
3,268 |
533 |
1,026 |
9,000 |
|
32 |
Genzyme | United States |
3,187 |
650 |
-17 |
8,477 |
|
33 |
Allergan | United States |
3,063 |
1,056 |
-127 |
8,423 |
|
34 |
Gilead Sciences | United States |
3,026 |
384 |
-1,190 |
6,772 |
|
35 |
CSL | Australia |
2,788 |
161 |
454 |
6,400 |
|
36 |
Chugai Pharmaceutical Co. | Japan |
2,787 |
467 |
328 |
5,962 |
|
37 |
Biogen Idec | United States |
2,683 |
718 |
218 |
5,907 |
|
38 |
Bausch & Lomb | United States |
2,292 |
197 |
15 |
5,830 |
|
39 |
Taiho Pharmaceutical Co. | Japan |
2,069 |
244 |
132 |
5,756 |
|
40 |
King Pharmaceuticals | United States |
1,989 |
254 |
289 |
5,191 |
|
41 |
Watson Pharmaceuticals | United States |
1,979 |
131 |
-445 |
5,126 |
|
42 |
Mitsubishi Pharma | Japan |
1,945 |
403 |
208 |
5,111 |
|
43 |
Shire | United Kingdom |
1,797 |
387 |
278 |
4,958 |
|
44 |
Cephalon | United States |
1,764 |
403 |
145 |
4,913 |
|
45 |
Dainippon Sumitomo Pharma | Japan |
1,763 |
350 |
193 |
3,750 |
OCS SILICA INCORPORATED 